Please Note: Due to volume considerations, not all questions can be answered. Questions most likely to be answered will be those of general interest to a broad group of visitors to this forum. Questions pertaining to a specific case; requests for diagnosis, medical advice, or second opinion; or requests for opinions about untested alternative therapies will generally not be answered.
The participation of Dr. Joseph McGowan in this
Forum is made possible by Boehringer Ingelheim.

|
 |
 |
switching nevirapine
Jul 21, 2007
hi there.
I am on Truvada and nevirapine. doing fine, VL undetectable, and cd4 in the 450 range. This combo is doing fine, however, I want to give Kaletra a go. I hear it has been found to be more fat friendly than NNRTI's mainly sustiva. If this is the case, Nevirapine is pretty similar....so that's my non-medical professional reasoning.
So, I have taken nevirapine once before and stopped for a few years, then started up again with this current combo. My question (finally:) is if the Kaletra does not work out, can I still go back to the old standby of nevirapine?
thanks
|
 |
 |
 |
 |
Response from Dr. Daar

Thank you for your post.
Let me answer your specific question first then make some general comments.
With regards to switching to Kaletra and if it doesn't work out going back to nevirapine. If you stop nevirapine while your viral load is undetectable then you will likely continue to have a virus susceptible to this drug in the future. Whether you will be able to go back to truvada with nevirapine will depend upon whether you develop resistance to tenofovir and/or FTC (components of truvada) in the interim. If you did you may need to use a new combination with nevirapine.
While it is certainly your decision as to whether to switch or not, I would encourage you to discuss this further with your provider. If you are tolerating your current regimen without side effects then it is very unlikely that you will develop fat problems in the future. You are correct that a very interesting recent study demonstrated less fat loss in those receiving kaletra than efavirenz the difference between the two, and the proportion that developed fat loss in both groups was very small when either of these drugs was combined with tenofovir and 3TC or FTC, which is what you are taking. There is something to be said for the old adage, "if it ain't broke, don't fix it."
Best,
Eric
|
|
 |
 Please remember that this forum is designed for educational purposes only, and experts are not engaged through this
forum in rendering legal or medical advice or professional services. Experts appearing on this page are independent and are solely responsible
for editing and fact-checking their material. Neither The Body nor any sponsor is the publisher or speaker of posted visitors' questions or the experts' material.
Questions and messages posted to this forum are not statements of advice, opinion, or information of The Body, Body Health Resources Corporation or any sponsor of this
forum. While neither The Body nor Body Health Resources Corporation regularly reviews posted content, we reserve the right to delete, move, or
edit postings if we deem it appropriate under the circumstances. Visitors submitting questions remain solely responsible for the content of their
messages.
Information provided by experts is general only and should not be used for diagnosing or treating a health problem or a disease, or relied upon as
legal or other professional advice. This information is not a substitute for professional advice or care. If you have or suspect you may have a
health or legal problem, you should consult your own health care provider or your attorney.
Copyright notice.
|
|
|
|